Skip to contentOrbiMed Capital GP IV LLC — Relypsa Inc insider: 72 transactions · InsiderLensOrbiMed Capital GP IV LLC
- 10% owner at Relypsa Inc · on record since Nov 20, 2013
- 10% owner at Anthera Pharmaceuticals Inc · on record since Oct 4, 2010
- Director at Anthera Pharmaceuticals Inc · on record since May 27, 2011
- 10% owner at INTERCEPT PHARMACEUTICALS INC · on record since Oct 16, 2012
- Director at INTERCEPT PHARMACEUTICALS INC · on record since Apr 15, 2013
- 10% owner at Mirati Therapeutics, Inc. · on record since Jul 16, 2013
- 10% owner at Otonomy, Inc. · on record since Aug 19, 2014
- Director at Otonomy, Inc. · on record since Nov 30, 2015
- Director at BOLD ENERGY INC. · on record since Jul 19, 2016
- 10% owner at BOLD ENERGY INC. · on record since Jul 19, 2016
- 10% owner at ACTELIS NETWORKS INC · on record since Nov 20, 2017
- Director at ARMO BioSciences, Inc. · on record since Jan 30, 2018
- 10% owner at ARMO BioSciences, Inc. · on record since Jan 30, 2018
- 10% owner at Principia Biopharma Inc. · on record since Sep 20, 2018
- Director at Alector, Inc. · on record since Feb 11, 2019
- 10% owner at Alector, Inc. · on record since Feb 11, 2019
- 10% owner at TELA Bio, Inc. · on record since Nov 13, 2019
- Director at Acutus Medical, Inc. · on record since Aug 12, 2020
- 10% owner at Acutus Medical, Inc. · on record since Aug 12, 2020
Insider trading activity of OrbiMed Capital GP IV LLC
- Transactions on record
- 72
- since May 11, 2011
- Open-market buys
- 5
- $21.3M
- Open-market sells
- 32
- $137.8M
- Companies traded
- 9
- last filing Aug 9, 2019
Figures computed from official regulatory filings — methodology.
Companies where OrbiMed Capital GP IV LLC has traded
- Alector, Inc.2 tx · $11.6M · Aug 9, 2019
- Principia Biopharma Inc.1 tx · $30.3M · May 22, 2019
- ARMO BioSciences, Inc.2 tx · $205.9M · Jun 22, 2018
- BOLD ENERGY INC.9 tx · $5.7M · Mar 12, 2018
- Otonomy, Inc.10 tx · $12.4M · Nov 24, 2015
- Relypsa Inc23 tx · $60.6M · May 20, 2015
- Mirati Therapeutics, Inc.1 tx · $2M · Feb 5, 2015
- INTERCEPT PHARMACEUTICALS INC12 tx · $31M · Aug 11, 2014
- Anthera Pharmaceuticals Inc12 tx · $6.3M · Feb 1, 2013
Track record of OrbiMed Capital GP IV LLC
Statistical track record
Free- Open-market buys
- 5
- Last buy
- Feb 3, 2015
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of OrbiMed Capital GP IV LLC
Co-insiders of OrbiMed Capital GP IV LLC
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
5AM VENTURES III, L.P.BOLD ENERGY INC. +1
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Aug 9, 2019 | Sell | -157,636 | 17.90 USD | $2.8M | SEC |
| Aug 9, 2019 | Sell | -492,364 | 17.90 USD | $8.8M | SEC |
| May 22, 2019 | Sell | -1,000,000 | 30.25 USD | $30.3M | SEC |
| Jun 22, 2018 | Other | -3,709,356 | 50.00 USD | $185.5M | SEC |
| Jun 22, 2018 | Other | -409,547 | 50.00 USD | $20.5M | SEC |
| Mar 12, 2018 | Sell | -47,395 | 35.86 USD | $1.7M | SEC |
| Mar 12, 2018 | Sell | -16,937 | 34.92 USD | $591.4K | SEC |
| Mar 12, 2018 | Sell | -21,300 | 34.67 USD | $738.5K | SEC |
| Mar 12, 2018 | Sell | -11,305 | 36.44 USD | $412K | SEC |
| Mar 12, 2018 | Sell | -58,428 | 34.06 USD | $2M | SEC |
| Mar 12, 2018 | Sell | -1,066 | 36.04 USD | $38.4K | SEC |
| Sep 11, 2017 | OtherD | -5,000 | 0.00 USD | $0 | SEC |
| Sep 11, 2017 | Sell | -5,000 | 22.35 USD | $111.8K | SEC |
| Sep 11, 2017 | Other | 5,000 | 15.03 USD | $75.2K | SEC |
| Nov 24, 2015 | Sell | -83,900 | 28.59 USD | $2.4M | SEC |
| Nov 24, 2015 | Sell | -80,800 | 28.45 USD | $2.3M | SEC |
| Nov 24, 2015 | Sell | -36,100 | 28.75 USD | $1M | SEC |
| Nov 19, 2015 | Sell | -200 | 29.09 USD | $5.8K | SEC |
| Nov 19, 2015 | Sell | -10,898 | 28.80 USD | $313.9K | SEC |
| Nov 19, 2015 | Sell | -127,300 | 28.60 USD | $3.6M | SEC |
| May 20, 2015 | Sell | -1,457,551 | 34.13 USD | $49.7M | SEC |
| Feb 5, 2015 | Buy | 100,000 | 20.00 USD | $2M | SEC |
| Sep 18, 2014 | Sell | -42,400 | 25.45 USD | $1.1M | SEC |
| Sep 18, 2014 | Sell | -2,600 | 26.06 USD | $67.8K | SEC |
| Sep 18, 2014 | Sell | -49,000 | 25.07 USD | $1.2M | SEC |